Dried Blood Spot Collection Cards Market to Reach USD 422.03 Million by 2031 | Straits Research

Dried Blood Spot Collection Cards Market

Dried Blood Spot Collection Cards Market Insights | Key Players & Growth Opportunities

According to Straits Research, the global Dried Blood Spot (DBS) Collection Cards Market was valued at USD 296.51 Million in 2022. It is projected to reach USD 422.03 Million by 2031, growing at a CAGR of 4% during the forecast period (2023–2031). DBS collection cards are widely used for sample collection, transportation, and long-term storage in clinical and research applications. These cards enable easy, cost-effective, and stable storage of blood samples, making them essential in newborn screening, infectious disease testing, forensic analysis, and therapeutic drug monitoring.

Dried Blood Spot Collection Cards Market Categorization

By Application

  1. Newborn Screening (NBS) – A primary driver for the DBS market, ensuring early detection of metabolic and genetic disorders in infants.
  2. Infectious Diseases Testing – Used extensively for HIV, hepatitis, and other viral/bacterial infection screenings.
  3. Therapeutic Drug Monitoring – Facilitates accurate and long-term drug concentration analysis, critical for personalized medicine.
  4. Forensics – Essential for DNA analysis and criminal investigations, aiding in case resolution.
  5. CRO/Research – Increasing use in contract research organizations (CROs) and academia for epidemiological and clinical studies.

By Card Type

  1. Whatman 903 – A globally recognized filter paper known for its superior sample retention.
  2. Ahlstrom 226 – Widely used for its high absorbency and protein stabilization properties.
  3. FTA – A specialized card for DNA preservation and genomic research.
  4. Others – Encompasses various alternative formats used in specialized research applications.

Download Free Sample Report with Complimentary Analyst Consultation :  https://straitsresearch.com/report/dried-blood-spot-collection-cards-market/request-sample

Geographic Overview

1. North America

  • The United States dominates due to the high adoption of DBS cards in newborn screening programs and personalized medicine.
  • Growing focus on home-based diagnostics and decentralized healthcare services is further fueling market growth.

2. Europe

  • Countries like Germany, the UK, and France are leading due to strong government support for clinical research.
  • Presence of major pharmaceutical and biotechnology firms investing in DBS technology.

3. Asia-Pacific

  • China and Japan are major players due to their rising healthcare expenditure and growing adoption of advanced diagnostic tools.
  • Expanding CRO networks and research initiatives drive the market in the region.

4. Latin America

  • Brazil and Mexico are key contributors, leveraging DBS technology for infectious disease surveillance.
  • Government-funded health programs are supporting DBS sample collection in rural areas.

Top Players in the Dried Blood Spot Collection Cards Market

  1. CENTOGENE
  2. Archimedlife
  3. Shimadzu Corporation
  4. Danaher (Pall Corporation)
  5. Qiagen
  6. PerkinElmer
  7. Eastern Business Form
  8. Ahlstrom-Munksjö
  9. F. Hoffmann-La Roche

Key Unit Economics for Businesses and Startups

  • Low Sample Collection Cost – DBS cards significantly reduce expenses associated with sample collection and storage, making them an ideal solution for low-resource settings.
  • Minimal Logistic Challenges – Unlike conventional liquid blood samples, DBS samples can be transported without refrigeration, reducing shipping costs.
  • Scalability – Businesses entering the DBS market can scale operations efficiently due to the low infrastructure requirements for sample processing.
  • Increased Demand for Personalized Medicine – With a shift towards customized healthcare solutions, DBS cards provide a cost-effective method for long-term monitoring and genetic testing.

Dried Blood Spot Collection Cards Market Operational Factors

  • Regulatory Compliance – Strict guidelines from FDA, WHO, and European health agencies are shaping the market, ensuring sample integrity and usability.
  • Technological Innovations – Advancements in automated sample analysis and AI-driven diagnostics are enhancing the capabilities of DBS cards.
  • Integration with Digital Health – Cloud-based sample tracking and data management are improving accessibility and reliability.
  • Increasing Government Support – Public health initiatives and screening programs are driving widespread adoption across developed and developing regions.

Why Straits Research?

Straits Research provides in-depth industry analysis, offering accurate market forecasts, key player insights, and data-driven recommendations for strategic business decisions.

Contact Us:

Email: sales@straitsresearch.com
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
Address: 825 3rd Avenue, New York, NY, USA, 10022

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *